UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low recruitment drives the decline of red porgy (Pagrus pagrus) along the southeast USA Atlantic coast: Inferences from fishery-independent trap and video monitoring

PloS one, 2023-07, Vol.18 (7), p.e0286078-e0286078

2023

Volltextzugriff (PDF)

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (5), p.2815-2825

2006

Volltextzugriff (PDF)

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Clinical cancer research, 2017-11, Vol.23 (22), p.6812-6822

2017

Volltextzugriff (PDF)

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Clinical cancer research, 2015-03, Vol.21 (6), p.1273-1280

2015

Volltextzugriff (PDF)

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1148-1159

2008

Volltextzugriff (PDF)

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2103-2105

2017

Volltextzugriff (PDF)

Biology of Prostate-Specific Antigen

Journal of clinical oncology, 2003-01, Vol.21 (2), p.383-391

2003

Volltextzugriff (PDF)

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2010-03, Vol.28 (9), p.1496-1501

2010

Volltextzugriff (PDF)

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

Molecular cancer research, 2015-01, Vol.13 (1), p.98-106

2015

Volltextzugriff (PDF)

Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (3), p.1050-1055

2013

Volltextzugriff (PDF)

Neoadjuvant Enzalutamide Prior to Prostatectomy

Clinical cancer research, 2017-05, Vol.23 (9), p.2169-2176

2017

Volltextzugriff (PDF)

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Clinical cancer research, 2021-07, Vol.27 (13), p.3610-3619

2021

Volltextzugriff (PDF)

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer

Journal of clinical oncology, 2012-02, Vol.30 (5), p.507-512

2012

Volltextzugriff (PDF)

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

Clinical cancer research, 2009-09, Vol.15 (18), p.5794-5802

2009

Volltextzugriff (PDF)

Androgen Receptor Phosphorylation and Stabilization in Prostate Cancer by Cyclin-Dependent Kinase 1

Proceedings of the National Academy of Sciences - PNAS, 2006-10, Vol.103 (43), p.15969-15974

2006

Volltextzugriff (PDF)

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3461-3467

1999

Volltextzugriff (PDF)

Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor

The Journal of biological chemistry, 2002-07, Vol.277 (29), p.26321-26326

2002

Volltextzugriff (PDF)

Increased fishery-independent sampling effort results in improved population estimates for multiple target species

Frontiers in Marine Science, 2023-06, Vol.10

2023

Volltextzugriff (PDF)

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

Cancer research (Chicago, Ill.), 1999-06, Vol.59 (11), p.2511-2515

1999

Volltextzugriff (PDF)

Incorporating depth into habitat use descriptions for sailfish Istiophorus platypterus and habitat overlap with other billfishes in the western North Atlantic

Marine ecology. Progress series (Halstenbek), 2020-03, Vol.638, p.137-148

2020

Volltextzugriff (PDF)

Comparison of video and traps for detecting reef fishes and quantifying species richness in the continental shelf waters of the southeast USA

Marine ecology. Progress series (Halstenbek), 2022-10, Vol.698, p.111-123

2022

Volltextzugriff (PDF)

Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer

BJU international, 2012-12, Vol.110 (11), p.1729-1735

2012

Volltextzugriff (PDF)

Celecoxib Versus Placebo for Men With Prostate Cancer and a Rising Serum Prostate-Specific Antigen After Radical Prostatectomy and/or Radiation Therapy

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2723-2728

2006

Volltextzugriff (PDF)

Is the flare phenomenon clinically significant?

Urology (Ridgewood, N.J.), 2001-08, Vol.58 (2), p.5-9

Bubley, Glenn J

2001

Volltextzugriff (PDF)

Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

The New England journal of medicine, 1995-05, Vol.332 (21), p.1393-1398

1995

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(219)

Publikationsform

Artikel
(244)
Tagungsberichte
(8)

Sprache

Englisch
(252)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(43)
Clinical Cancer Research
(18)
Urology
(15)
Cancer Research
(14)
The Journal Of Urology
(13)
Cell
(9)
Cell Reports
(9)
Bju International
(7)
The New England Journal Of Medicine
(6)
Bioorganic & Medicinal Chemistry Letters
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Low recruitment drives the decline of red porgy (Pagrus pagrus) along the southeast USA Atlantic coast: Inferences from fishery-independent trap and video monitoring

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Biology of Prostate-Specific Antigen

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer

Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4

Neoadjuvant Enzalutamide Prior to Prostatectomy

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

Androgen Receptor Phosphorylation and Stabilization in Prostate Cancer by Cyclin-Dependent Kinase 1

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor

Increased fishery-independent sampling effort results in improved population estimates for multiple target species

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

Incorporating depth into habitat use descriptions for sailfish Istiophorus platypterus and habitat overlap with other billfishes in the western North Atlantic

Comparison of video and traps for detecting reef fishes and quantifying species richness in the continental shelf waters of the southeast USA

Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer

Celecoxib Versus Placebo for Men With Prostate Cancer and a Rising Serum Prostate-Specific Antigen After Radical Prostatectomy and/or Radiation Therapy

Is the flare phenomenon clinically significant?

Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

Suchergebnisse filtern